RNAi Technology and Investigation on Possible Vaccines to Combat SARS-CoV-2 Infection

被引:3
|
作者
Talukder, Pratik [1 ]
Chanda, Sounak [1 ]
机构
[1] Univ Engn & Management, Dept Biotechnol, St 03,Act Area 3,B-5, Kolkata 700156, W Bengal, India
关键词
COVID-19; Vaccine; ACE2; receptors; Antibody; Antigen; siRNA; Gene silencing; RESPIRATORY SYNDROME CORONAVIRUS; SARS-COV; PROTEIN; IDENTIFICATION; NANOCARRIERS; MODEL; MICE;
D O I
10.1007/s12010-021-03548-2
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Coronavirus disease of 2019 (COVID-19) pandemic, taking place globally, occurs as a result of the SARS-CoV-2 viral infection which has caused death of innumerable numbers of people and is responsible for a massive drop in the global economy. Millions of people are infected, and the death rate is also quite high in different countries. So, there is an urgent requirement of the invention of some effective and efficient drugs that can be effective against this deadly viral infection. The invention of new drugs and vaccine has become a matter of utmost importance to stop the mayhem of coronavirus pandemic. In the middle of such a deadly pandemic, the necessity of development of a vaccine is of high importance in this context. Among all the popular methods of vaccine development, the mRNA vaccines turned out to be the one of the most versatile vaccine with quick responses. However, in this review, we have explained all the possible types of vaccines available including DNA vaccines, RNA vaccines, and live and attenuated vaccines. Their effectiveness, importance, and application of the vaccines against the SARS-CoV-2 virus have been discussed. Research is also being conducted in the field of gene silencing, and one of the best possible ways to combat the virus at the molecular level is by applying RNAi technology. The modified siRNA molecules can be used to silence the gene expression of the virus. A summarization of the virus's behavior, characteristics, and the methods by which RNAi technology can be administered to control the virus is depicted in this study.
引用
收藏
页码:1744 / 1756
页数:13
相关论文
共 50 条
  • [31] RNAi-mediated inhibition of SARS-CoV-2: applications and challenges
    Sanyal, Debosmita
    Chaubey, Binay
    FUTURE VIROLOGY, 2024, 19 (2-4) : 127 - 143
  • [32] SARS-CoV-2: vaccines in the pandemic era
    Dan-Dan Li
    Qi-Han Li
    Military Medical Research, 8
  • [33] SARS-CoV-2 vaccines: Lights and shadows
    Angeli, Fabio
    Spanevello, Antonio
    Reboldi, Gianpaolo
    Visca, Dina
    Verdecchia, Paolo
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2021, 88 : 1 - 8
  • [34] Mutations in SARS-CoV-2: Insights on structure, variants, vaccines, and biomedical interventions
    Abulsoud, Ahmed I.
    El-Husseiny, Hussein M.
    El-Husseiny, Ahmed A.
    El-Mahdy, Hesham A.
    Ismail, Ahmed
    Elkhawaga, Samy Y.
    Khidr, Emad Gamil
    Fathi, Doaa
    Mady, Eman A.
    Najda, Agnieszka
    Algahtani, Mohammad
    Theyab, Abdulrahman
    Alsharif, Khalaf F.
    Albrakati, Ashraf
    Bayram, Roula
    Abdel-Daim, Mohamed M.
    Doghish, Ahmed S.
    BIOMEDICINE & PHARMACOTHERAPY, 2023, 157
  • [35] SARS-CoV-2: Immune Response Elicited by Infection and Development of Vaccines and Treatments
    Canedo-Marroquin, Gisela
    Saavedra, Farides
    Andrade, Catalina A.
    Berrios, Roslye, V
    Rodriguez-Guilarte, Linmar
    Opazo, Maria C.
    Riedel, Claudia A.
    Kalergis, Alexis M.
    FRONTIERS IN IMMUNOLOGY, 2020, 11
  • [36] Vaccines against SARS-CoV-2 variants and future pandemics
    Park, Taeyoung
    Hwang, Hyogyeong
    Moon, Suhyeong
    Kang, Sang Gu
    Song, Seunghyup
    Kim, Young Hun
    Kim, Hanbi
    Ko, Eun-Ju
    Yoon, Soon-Do
    Kang, Sang-Moo
    Hwang, Hye Suk
    EXPERT REVIEW OF VACCINES, 2022, 21 (10) : 1363 - 1376
  • [37] Insights into SARS-CoV-2 evolution, potential antivirals, and vaccines
    Abdel-Moneim, Ahmed S.
    Abdelwhab, Elsayed M.
    Memish, Ziad A.
    VIROLOGY, 2021, 558 : 1 - 12
  • [38] DNA Vaccines for Epidemic Preparedness: SARS-CoV-2 and Beyond
    Maslow, Joel N.
    Kwon, Ijoo
    Kudchodkar, Sagar B.
    Kane, Deborah
    Tadesse, Amha
    Lee, Hyojin
    Park, Young K.
    Muthumani, Kar
    Roberts, Christine C.
    VACCINES, 2023, 11 (06)
  • [39] Seroconversion to mRNA SARS-CoV-2 Vaccines in Hematologic Patients
    Fattizzo, Bruno
    Bortolotti, Marta
    Rampi, Nicolo
    Cavallaro, Francesca
    Giannotta, Juri Alessandro
    Bucelli, Cristina
    Cassin, Ramona
    Da Via, Matteo Claudio
    Galassi, Giulia
    Noto, Alessandro
    Pettine, Loredana
    Rossi, Francesca Gaia
    Sciume, Mariarita
    Ceriotti, Ferruccio
    Consonni, Dario
    Barcellini, Wilma
    Baldini, Luca
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [40] Occult SARS-CoV-2 infection; a possible hypothesis for viral relapse
    Elberry, Mostafa H.
    Ahmed, Hussien
    MEDICAL HYPOTHESES, 2020, 144